Skip to main content
. 2024 May 9;19(5):e0302579. doi: 10.1371/journal.pone.0302579

Fig 2. Levels of Anti-SARS-CoV-2 S antibody titers (U/ml) measured during two time points (T1 and T2).

Fig 2

T1 ranges between 2 weeks and 2 months after receiving the COVID-19 booster dose. T2 represents a 6-month duration after the initial collection. These measurements were taken from participants who had received the Pfizer-BioNTech (BNT162b2), AstraZeneca, or Sputnik V vaccine. //The upper values (>200 U/ml) do not follow the same scale as the lower ones (≤ 200 U/ml).